Loading video...

Video Failed to Load

Go Home

Induction medication for emergency intubation — does the choice matter? NEJM Editorial Fellow Katerina Lin, MD, explains a randomized trial to determine the effects of ketamine vs. etomidate for induction of anesthesia during emergency tracheal intubation. Full RSI trial results:

NEJM's profile picture

NEJM

981,742 subscribers

21,895 views • 3 months ago •via X (Twitter)

LIVE

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

NEJM Editorial Fellow Minali Nigam, MD, shares the key results of the ORIENTAL-MeVO trial, which investigated whether endovascular thrombectomy for acute ischemic stroke improves functional outcomes in patients with medium-vessel occlusion and moderate-to-severe deficits. Read the full trial results:
1:28

NEJM Editorial Fellow Minali Nigam, MD, shares the key results of the ORIENTAL-MeVO trial, which investigated whether endovascular thrombectomy for acute ischemic stroke improves functional outcomes in patients with medium-vessel occlusion and moderate-to-severe deficits. Read the full trial results:

NEJM

16,994 views • 3 days ago

Pharmacologic treatment options for cancer cachexia are limited. NEJM Editorial Fellow Harleen Marwah, MD, summarizes research on the safety and efficacy of the monoclonal antibody ponsegromab for treating cancer cachexia. Read the full trial results:
1:40

Pharmacologic treatment options for cancer cachexia are limited. NEJM Editorial Fellow Harleen Marwah, MD, summarizes research on the safety and efficacy of the monoclonal antibody ponsegromab for treating cancer cachexia. Read the full trial results:

NEJM

16,522 views • 1 year ago

NEJM Editorial Fellow Harleen Marwah, MD (Harleen Marwah, MD, MS), summarizes the API-CAT trial.
2:01

NEJM Editorial Fellow Harleen Marwah, MD (Harleen Marwah, MD, MS), summarizes the API-CAT trial.

NEJM

11,385 views • 1 year ago

How is cumulative medical imaging in childhood associated with cancer risk? NEJM Editorial Fellow Katerina Lin, MD, summarizes a recent retrospective cohort study involving 3 million children. Read the full study:
1:48

How is cumulative medical imaging in childhood associated with cancer risk? NEJM Editorial Fellow Katerina Lin, MD, summarizes a recent retrospective cohort study involving 3 million children. Read the full study:

NEJM

22,502 views • 3 months ago

Weight Regain after Stopping Obesity Medications: NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD (Raja-Elie Abdulnour), explains a recent meta-analysis that showed projected return to baseline weight within 2 years. Full context and comment by Sarah E. Post, MD: Visit for more Insights You’ll Love This Week, including: 🩺 A Streamlined Approach to Blood Pressure Measurement 🎗️ Risk-Based Breast Cancer Screening vs. Annual Mammograms 🧬 Predicting Acute Chest Syndrome in Sickle Cell Disease 💉 Ketamine vs. Etomidate for Emergent Intubation #MedTwitter
1:04

Weight Regain after Stopping Obesity Medications: NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD (Raja-Elie Abdulnour), explains a recent meta-analysis that showed projected return to baseline weight within 2 years. Full context and comment by Sarah E. Post, MD: Visit for more Insights You’ll Love This Week, including: 🩺 A Streamlined Approach to Blood Pressure Measurement 🎗️ Risk-Based Breast Cancer Screening vs. Annual Mammograms 🧬 Predicting Acute Chest Syndrome in Sickle Cell Disease 💉 Ketamine vs. Etomidate for Emergent Intubation #MedTwitter

NEJM

20,543 views • 5 months ago

NEJM Editorial Fellow Katerina Lin, MD, summarizes the diagnosis and treatment of complex regional pain syndrome (CRPS), a rare limb-pain disorder. Learn more about this disorder in a December 10, 2025, Clinical Practice article:
1:39

NEJM Editorial Fellow Katerina Lin, MD, summarizes the diagnosis and treatment of complex regional pain syndrome (CRPS), a rare limb-pain disorder. Learn more about this disorder in a December 10, 2025, Clinical Practice article:

NEJM

17,459 views • 1 month ago

Monoclonal gammopathy of undetermined significance (MGUS) is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. NEJM Editorial Fellow Katerina Lin, MD, shares some key points from a review published in October. Read the full article:
1:18

Monoclonal gammopathy of undetermined significance (MGUS) is a common, asymptomatic plasma-cell disorder in older adults that can progress to cancer or systemic illness. NEJM Editorial Fellow Katerina Lin, MD, shares some key points from a review published in October. Read the full article:

NEJM

16,361 views • 5 months ago

Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. The CHALLENGE trial sought to address this knowledge gap. NEJM Editorial Fellow Sarah Gorey, MB (Sarah Gorey), explains in this 60-Second Journal Club video. Read the full trial results:
2:26

Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence is lacking. The CHALLENGE trial sought to address this knowledge gap. NEJM Editorial Fellow Sarah Gorey, MB (Sarah Gorey), explains in this 60-Second Journal Club video. Read the full trial results:

NEJM

12,389 views • 1 year ago

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:
0:58

In an international, randomized trial involving patients with acute venous thromboembolism, the risk of clinically relevant bleeding was significantly lower with apixaban than with rivaroxaban during the 3-month treatment period. Full COBRRA trial results and Research Summary:

NEJM

12,209 views • 4 months ago

In this 60-Second Journal Club, NEJM Editorial Fellow Abarna Pearl, MD, MPH, summarizes the BALANCE trial comparing antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. Read the full article and accompanying Research Summary:
1:48

In this 60-Second Journal Club, NEJM Editorial Fellow Abarna Pearl, MD, MPH, summarizes the BALANCE trial comparing antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. Read the full article and accompanying Research Summary:

NEJM

10,641 views • 1 year ago

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:
1:14

Our latest video in our partnership with Dr. Glaucomflecken summarizes a new trial investigating the mass administration of ivermectin for reducing malaria transmission. Read the full results of the BOHEMIA trial for free:

NEJM

19,398 views • 8 months ago

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial investigating the effectiveness of shunt surgery for idiopathic normal-pressure hydrocephalus. Read the full results for free: #neurology
1:23

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial investigating the effectiveness of shunt surgery for idiopathic normal-pressure hydrocephalus. Read the full results for free: #neurology

NEJM

56,763 views • 6 months ago

Drs. Greg Katz, MD, Shreya P. Trivedi MD, MHPE & Abby Schubach MD discuss the NordICC trial: Does colonoscopy reduce colorectal cancer incidence? Hear more in the latest episode of Beyond Journal Club, a CORE IM in collaboration with NEJM Group:
0:50

Drs. Greg Katz, MD, Shreya P. Trivedi MD, MHPE & Abby Schubach MD discuss the NordICC trial: Does colonoscopy reduce colorectal cancer incidence? Hear more in the latest episode of Beyond Journal Club, a CORE IM in collaboration with NEJM Group:

NEJM

14,595 views • 2 years ago

The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free:
1:24

The latest video in our partnership with Dr. Glaucomflecken summarizes the results of the VANISH2 trial, which compared catheter ablation versus antiarrhythmic drug therapy for ventricular tachycardia. View the full article for free:

NEJM

50,348 views • 1 year ago

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial that evaluated whether management of shock without early arterial catheterization is noninferior to the practice of early catheter insertion with regard to death from any cause at day 28. Read the full results for free:
1:18

Our latest video in our partnership with Dr. Glaucomflecken summarizes the results of a trial that evaluated whether management of shock without early arterial catheterization is noninferior to the practice of early catheter insertion with regard to death from any cause at day 28. Read the full results for free:

NEJM

47,782 views • 7 months ago

Ondansetron is often prescribed at ED discharge for children seen for gastroenteritis to reduce further symptoms, but evidence to support doing so is limited. A new trial investigates whether postdischarge ondansetron is beneficial. Full trial results:
1:47

Ondansetron is often prescribed at ED discharge for children seen for gastroenteritis to reduce further symptoms, but evidence to support doing so is limited. A new trial investigates whether postdischarge ondansetron is beneficial. Full trial results:

NEJM

14,351 views • 11 months ago

What is the appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation? View the full results of the AQUATIC trial:
1:20

What is the appropriate antithrombotic regimen for patients with chronic coronary syndrome who are at high atherothrombotic risk and receiving long-term oral anticoagulation? View the full results of the AQUATIC trial:

NEJM

16,263 views • 8 months ago

Could clesrovimab, a human RSV monoclonal antibody, reduce the incidence of RSV infection in preterm and full-term infants? Find out in the latest video in our partnership with Dr. Glaucomflecken. Read the full results of the CLEVER trial for free:
1:24

Could clesrovimab, a human RSV monoclonal antibody, reduce the incidence of RSV infection in preterm and full-term infants? Find out in the latest video in our partnership with Dr. Glaucomflecken. Read the full results of the CLEVER trial for free:

NEJM

46,802 views • 8 months ago